Inquis Medical today announced findings from the AVENTUS trial evaluating the safety and efficacy of its Aventus thrombectomy ...

The company reports that NUOS 3 can enable patients who have been declared clinically dead — at times for over 30 minutes — and later resuscitated to regain the ability to communicate. Despite ...

ElectroCore (Nasdaq:ECOR) announced today that it completed its previously announced acquisition of NeuroMetrix  (Nasdaq:NURO ...

Rhythm Technologies (Nasdaq: IRTC) shares are on the rise on first-quarter results that were mixed compared to the Wall ...

Aktiia announced today that it raised an oversubscribed $42 million Series B funding round and introduced its new "Hilo" ...

The Financial Times reports today that histotripsy tech developer HistoSonics is considering a potential sale after receiving ...

Neuralink said on social media that it received FDA breakthrough device designation for treating individuals with severe ...

Stryker reported Street-beating financial results and upped its sales forecast, but said tariffs will decrease previously ...